Mushrooms, Tumors, and Immunity: An Update
- 1 May 2004
- journal article
- review article
- Published by Frontiers Media SA in Experimental Biology and Medicine
- Vol. 229 (5), 393-406
- https://doi.org/10.1177/153537020422900507
Abstract
There is significant interest in the use of mushrooms and/or mushroom extracts as dietary supplements based on theories that they enhance immune function and promote health. To some extent, select mushrooms have been shown to have stimulatory action on immune responsiveness, particularly when studied in vitro. However, despite their widespread use for potential health benefits, there is a surprising paucity of epidemiologic and experimental studies that address the biologic activities of mushrooms after oral administration to animals or humans. There have been a number of studies that have addressed the ability of mushrooms to modulate mononuclear cell activation and the phenotypic expression of cytokines and their cognate receptors. There have also been a number of attempts to determine antitumor activities of mushrooms. Such studies are important because many of the components of mushrooms do potentially have significant biologic activity. All data, however, should be tempered by the Possibility that there are toxic levels of metals, including arsenic, lead, cadmium, and mercury as well as the presence of radioactive contamination with 137Cs. In this review, we will Present the comparative biology with respect to both immunological and antitumor activities of mushroom extracts and also highlight the need for further evidence-based research.Keywords
This publication has 81 references indexed in Scilit:
- Inhibition of Human Colon Carcinoma Development by Lentinan from Shiitake Mushrooms (Lentinus edodes)The Journal of Alternative and Complementary Medicine, 2002
- IFN-γ and pro-inflammatory cytokine production by antigen-presenting cells is dictated by intracellular thiol redox status regulated by oxygen tensionEuropean Journal of Immunology, 2002
- Dectin-1 Is A Major β-Glucan Receptor On MacrophagesThe Journal of Experimental Medicine, 2002
- Antioxidant, Anti-inflammatory, and Antitumor Activities of Culinary-Medicinal Mushroom Pleurotus pufmonanus (Fr.) Quel. (Agaricomycetideae)International Journal of Medicinal Mushrooms, 2002
- Inhibitory Effects of Edible Higher Basidiomycetes Mushroom Extracts on Mouse Type IV AllergyInternational Journal of Medicinal Mushrooms, 2002
- Antitumor Activity and Hematopoietic Response of a b-Glucan Extracted from an Edible and Medicinal Mushroom Sparassis crispa Wulf.: Fr. (Aphyllophoromycetideae)International Journal of Medicinal Mushrooms, 2002
- A (1→3)-β-D-linked heptasaccharide is the unit ligand for glucan pattern recognition receptors on human monocytesMicrobes and Infection, 2001
- An Improved Method for the Isolation of Lentinan from the Edible and Medicinal Shiitake Mushroom, Lentinus edodes (Berk.) Sing. (Agaricomycetideae)International Journal of Medicinal Mushrooms, 2001
- Cytokine synthesis of human monocytes stimulated by triple or single helical conformer of an antitumour (1 → 3)-β-D-glucan preparation, sonifilanZentralblatt für Bakteriologie, 1998
- Ligand Binding to the (1 → 3)-β-D-Glucan Receptor Stimulates NFκB Activation, but Not Apoptosis in U937 CellsBiochemical and Biophysical Research Communications, 1998